The Valley Desk

NCT00035308 · Interventional trial

Safety and Efficacy Study of LJP 394 (Abetimus Sodium) to Treat Lupus Kidney Disease

Overall registry status Completed

Phase 3

Conditions Autoimmune Diseases, Immunologic Diseases, Lupus Glomerulonephritis, Lupus Nephritis, Systemic Lupus Erythematosus

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov